Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Signaling pathways governing glioma cancer stem cells behavior
Ava Nasrolahi, Shirin Azizidoost, Klaudia Radoszkiewicz, et al.
Cellular Signalling (2022) Vol. 101, pp. 110493-110493
Closed Access | Times Cited: 25

Showing 25 citing articles:

Synthesis and exploration of anticancer potential of spirocyclic 1,2,3-triazoline and aziridine derivatives of natural eudesmanolide isoalantolactone
Sergey S. Patrushev, Daria O Kichkina, Arseny D. Moralev, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108124-108124
Closed Access
Decoding the Role of Kinesin Superfamily Proteins in Glioma Progression
Mohamed J. Saadh, Zahraa Sabah Ghnim, Morug Salih Mahdi, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 1
Closed Access
Radiogenomics and machine learning predict oncogenic signaling pathways in glioblastoma
Abdul Basit Ahanger, Syed Wajid Aalam, Tariq Masoodi, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Cellular Aging and Senescence in Cancer: A Holistic Review of Cellular Fate Determinants
Muhammad Tufail, Yuqi Huang, Jia-Ju Hu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 3
Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells
Queenie Fernandes, Lubna Therachiyil, Abdul Quaiyoom Khan, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 191, pp. 106586-106586
Open Access | Times Cited: 10
Glioma Stem Cells—Features for New Therapy Design
Nives Pećina‐Šlaus, Reno Hrašćan
Cancers (2024) Vol. 16, Iss. 8, pp. 1557-1557
Open Access | Times Cited: 2
Prospects of marine-derived compounds as potential therapeutic agents for glioma
Ying Liu, Zhiyang Zhou, Shusen Sun
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 513-526
Open Access | Times Cited: 2
The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells
Małgorzata Kucińska, Julia Pospieszna, Jing Tang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116892-116892
Open Access | Times Cited: 2
The dual role of POSTN in maintaining glioblastoma stem cells and the immunosuppressive phenotype of microglia in glioblastoma
Hao Wang, Lin Yao, Jinming Chen, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemness
Shanchun Guo, Ramar Vanajothi, Alyssa A. Guo, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 9
Open Access | Times Cited: 7
Cysteine and glycine-rich protein 2 is crucial for maintaining the malignant phenotypes of gliomas through its action on Notch signalling cascade
Lingtong Liu, Fei Li, Lingxue Zhang, et al.
Toxicology and Applied Pharmacology (2024) Vol. 487, pp. 116969-116969
Closed Access | Times Cited: 1
Research progress on function and mechanism of long non-coding RNA in glioma
Feipeng Tai, Xueming Zhao
Cellular and Molecular Biology (2024) Vol. 70, Iss. 5, pp. 233-237
Open Access | Times Cited: 1
PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways
Seong Hun Lim, Hyesung Lee, Hyun Ji Lee, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 7, pp. 1479-1487
Open Access | Times Cited: 1
Harnessing the role of aberrant cell signaling pathways in glioblastoma multiforme: a prospect towards the targeted therapy
S. M. Murshid Hasan, Zimam Mahmud, Mahmud Hossain, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
iPSC-Derived Glioblastoma Cells Have Enhanced Stemness Wnt/β-Catenin Activity Which Is Negatively Regulated by Wnt Antagonist sFRP4
Ishmat Ara Yasmin, Arun Dharmarajan, Sudha Warrier
Cancers (2023) Vol. 15, Iss. 14, pp. 3622-3622
Open Access | Times Cited: 4
EIF4A3 induced circGRIK2 promotes the malignancy of glioma by regulating the miR-1303/HOXA10 axis.
Fubin Li, Weihong Song, Lin Wu, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 5868-5886
Closed Access | Times Cited: 2
SENP1-Mediated deSUMOylation Regulates the Tumor Remodeling of Glioma Stem Cells Under Hypoxic Stress
Ping Wen, Haoran Li, Liang Liu, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access
Construction of Biomimetic Camouflaged Neutrophil Membrane Nanoparticles for Precise Delivery and Augmented Glioma Cancer Treatment
Yongyan Bi, Peiyu Qian, Zuopeng Su, et al.
Process Biochemistry (2024) Vol. 145, pp. 229-242
Closed Access
Novel tetrahydroquinoline derivatives induce ROS-mediated apoptosis in glioblastoma cells
Shabnaz Koochakkhani, Daniela S.N. Branco, Anxo Vila Alonso, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 200, pp. 106842-106842
Open Access
The Implication of Photodynamic Therapy Applied to the Level of Tumor Resection on Postoperative Cerebral Edema and Intracranial Pressure Changes in Gliomas
Jingxuan Li, Weijun Sun, Shaoshan Hu, et al.
Lasers in Surgery and Medicine (2024)
Closed Access
Unlocking the Potential of Circulating miRNAs as Biomarkers in Glioblastoma
Sanika Suvarnapathaki, Antolin Serrano-Farias, Jonathan C. Dudley, et al.
Life (2024) Vol. 14, Iss. 10, pp. 1312-1312
Open Access
Glioblastoma therapy: State of the field and future prospects
Nadia Allahyarzadeh Khiabani, Mohammad Amin Doustvandi, Darren Story, et al.
Life Sciences (2024) Vol. 359, pp. 123227-123227
Closed Access
Editorial: The role of STAT3 signaling pathway in tumor progression
Nan‐Shan Chang, Kenneth K.W. To, Yih‐Cherng Liou, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
New Strategies in Diagnosis and Treatments for Brain Tumors
Sven R. Kantelhardt
Cancers (2023) Vol. 15, Iss. 11, pp. 2879-2879
Open Access
Functional Roles of the lncRNA MALAT1 in Glioma
Arya Moftakhar, Sajad Najafi, Omid Anbiyaee, et al.
Current Cancer Therapy Reviews (2023) Vol. 20, Iss. 2, pp. 166-176
Closed Access
Page 1

Scroll to top